Overview
- Investigations follow reports that a six-year-old who received an experimental in vivo base-editing therapy for a brain disorder developed fever and kidney injury and died about one week later, with hospital reviewers saying an immune reaction to the viral delivery vector was the most likely cause.
- Science and Retraction Watch reported on July 23 that the child’s family paid about US$860,000 to help fund preclinical work and that both the payment and the human treatment were not disclosed in a February Nature paper describing only animal experiments.
- Nature has placed an Editor’s Note on the February paper and said it is investigating whether the manuscript omitted human treatment and relevant data, while Shanghai Jiao Tong University School of Medicine has set up a special task force for a separate internal probe.
- Official responses so far have been limited: regulators issued a small administrative fine to the treating hospital and the lead clinician received informal verbal counselling, and no public disciplinary action has been announced for the lead researcher.
- Experts who reviewed the case have questioned whether parents were fully informed, raised doubts about the validity of the reported animal data, and warned that the episode highlights known immune risks of viral delivery and gaps in disclosure and oversight that could prompt journal corrections or institutional reforms.